HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The related factors to the re-thrombosis of hemodialysis arteriovenous graft after endovascular salvage.

AbstractBACKGROUND:
Only a few issues of the related factors to hemodialysis access dysfunction have been evaluated, and the effects of antiplatelets to improve the patency of hemodialysis access remained controversial. Hence, this study aimed to determine the related factors to the re-thrombosis of arteriovenous grafts (AVGs) after endovascular treatment.
METHODS:
This retrospective study was conducted at a university-affiliated teaching hospital in Southern Thailand. All patients who underwent hemodialysis with thrombosed AVG, who had pharmacomechanical thrombolysis from January 2016 to December 2018, were enrolled. Post-intervention primary patency was analyzed by the Kaplan-Meier method, and the related factors to the re-thrombosis of AVG were evaluated using logistic regression.
RESULTS:
A total of 157 patients with thrombosed hemodialysis AVG were enrolled. The most common graft location and configuration was a forearm loop graft (65%). Post-intervention primary patency rate at 1, 3, and 6 months were 79.0%, 67.1%, and 54.0%, respectively. Diabetes mellitus (DM) was a significant related factor for re-thrombosis (hazard ratio [HR], 1.89; 95% confidence interval [CI], 1.20-2.98; p = 0.006). A single antiplatelet after the procedure was a protective factor for re-thrombosis (HR, 0.58; 95% CI, 0.38-0.89; p = 0.013). The median post-intervention primary patency was 15.7 months in the group of single antiplatelet usage, which was better than that of the non-antiplatelet group (p = 0.012).
CONCLUSION:
DM and antiplatelet usage were significant related factors to the re-thrombosis of hemodialysis AVG after endovascular salvage.
AuthorsPhurich Janjindamai, Keerati Hongsakul, Jitpreedee Sungsiri, Kittipitch Bannangkoon, Tippawan Liabsuetrakul
JournalSeminars in dialysis (Semin Dial) 2023 May-Jun Vol. 36 Issue 3 Pg. 208-213 ISSN: 1525-139X [Electronic] United States
PMID35503025 (Publication Type: Journal Article)
Copyright© 2022 Wiley Periodicals LLC.
Topics
  • Humans
  • Graft Occlusion, Vascular (etiology, therapy)
  • Vascular Patency
  • Renal Dialysis (adverse effects)
  • Arteriovenous Shunt, Surgical (adverse effects)
  • Retrospective Studies
  • Treatment Outcome
  • Blood Vessel Prosthesis Implantation
  • Risk Factors
  • Thrombosis (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: